Plague vaccine - aVaxziPen/University of Oxford
Alternative Names: Solid dose plague vaccine - aVaxziPen/University of OxfordLatest Information Update: 28 May 2023
At a glance
- Originator Enesi Pharma; University of Oxford
- Developer aVaxziPen; University of Oxford
- Class Plague vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Plague
Most Recent Events
- 28 May 2023 No recent reports of development identified for research development in Plague(Prevention) in United Kingdom (SC, Injection)
- 09 Apr 2019 Enesi Pharma and University of Oxford agree to co-develop adenovirus-based vaccine against Plague
- 09 Apr 2019 Early research in Plague (Prevention) in United Kingdom (SC)